The Wiley Prize in Biomedical Sciences is intended to recognize breakthrough research in pure or applied life science research that is distinguished by its excellence, originality and impact on our understanding of biological systems and processes. The award may recognize a specific contribution or series of contributions that demonstrate the nominee's significant leadership in the development of research concepts or their clinical application. Particular emphasis will be placed on research that champions novel approaches and challenges accepted thinking in the biomedical sciences. [1]
The Wiley Foundation, established in 2001, is the endowing body that supports the Wiley Prize in Biomedical Sciences. [2]
This international award is presented annually and consists of a $35,000 prize and a luncheon in honor of the recipient. The award is presented at a ceremony at The Rockefeller University, where the recipient delivers an honorary lecture as part of the Rockefeller University Lecture Series. [2]
As of 2016, six recipients have gone on to be awarded the Nobel Prize in Physiology or Medicine. [1]
Source: Wiley Foundation
H. Robert Horvitz of the Massachusetts Institute of Technology and Stanley J. Korsmeyer of the Dana Farber Cancer Institute – For his seminal research on programmed cell death and the discovery that a genetic pathway accounts for the programmed cell death within an organism, and Korsmeyer was chosen for his discovery of the relationship between human lymphomas and the fundamental biological process of apoptosis. Korsmeyer's experiments established that blocking cell death plays a primary role in cancer.
Andrew Z. Fire, of both the Carnegie Institution of Washington and the Johns Hopkins University; Craig C. Mello, of the University of Massachusetts Medical School; Thomas Tuschl, formerly of the Max-Planck Institute for Biophysical Chemistry in Goettingen, Germany, and most recently of The Rockefeller University; and David Baulcombe, of the Sainsbury Laboratory at the John Innes Centre in Norwich, England – For contributions to discoveries of novel mechanisms for regulating gene expression by small interfering RNAs (siRNA).
C. David Allis, Ph.D., Joy and Jack Fishman, Professor, Laboratory of Chromatin Biology and Epigenetics at the Rockefeller University in New York – For the significant discovery that transcription factors can enzymatically modify histones to regulate gene activity.
Peter Walter, a Howard Hughes Medical Institute investigator, and Professor and Chairman of the Department of Biochemistry & Biophysics at the University of California San Francisco, and Kazutoshi Mori, a professor of biophysics, in the Graduate School of Science at Kyoto University, in Japan – For the discovery of the novel pathway by which cells regulate the capacity of their intracellular compartments to produce correctly folded proteins for export.
Elizabeth H. Blackburn, Morris Herztein Professor of Biology and Physiology in the Department of Biochemistry and Biophysics at the University of California, San Francisco, and Carol Greider, Daniel Nathans Professor and Director of Molecular Biology & Genetics at Johns Hopkins University – For the discovery of telomerase, the enzyme that maintains chromosomal integrity and the recognition of its importance in aging, cancer and stem cell biology.
F. Ulrich Hartl, Director at the Max Planck Institute of Biochemistry, in Munich, Germany, and Arthur L. Horwich, Eugene Higgins Professor of Genetics and Pediatrics at the Yale University School of Medicine, and Investigator, Howard Hughes Medical Institute. [3] – For elucidation of the molecular machinery that guides proteins into their proper functional shape, thereby preventing the accumulation of protein aggregates that underlie many diseases, such as Alzheimer's and Parkinson's.
Richard P. Lifton of the Yale University School of Medicine. [4] – For the discovery of the genes that cause many forms of high and low blood pressure in humans.
Bonnie Bassler of the Department of Molecular Biology at Princeton University and the Howard Hughes Medical Institute. [1] – For pioneering investigations of quorum sensing, a mechanism that allows bacteria to "talk" to each other to coordinate their behavior, even between species.
Peter Hegemann, Professor of Molecular Biophysics, Humboldt University, Berlin; Georg Nagel, Professor of Molecular Plant Physiology, Department of Botany, University of Würzburg; and Ernst Bamberg, Professor and Director of the Dept of Biophysical Chemistry, Max Planck Institute for Biophysics, Frankfurt, Germany for their discovery of channelrhodopsins, a family of light-activated ion channels. The discovery has greatly enlarged and strengthened the new field of optogenetics. Channelrhodopsins also provide a high potential for biomedical applications such as the recovery of vision and optical deep brain stimulation for treatment of Parkinson's and other diseases, instead of the more invasive electrode-based treatments.
Lily Jan and Yuh Nung Jan of Howard Hughes Medical Institute at the University of California, San Francisco for their molecular identification of a founding member of a family of potassium ion channels that control nerve cell activity throughout the animal kingdom.
Michael Sheetz, Columbia University; James Spudich, Stanford University, and Ronald Vale, University of California, San Francisco for explaining how cargo is moved by molecular motors along two different systems of tracks within cells. [5]
Michael Young, Rockefeller University; Jeffrey Hall, Brandeis University (Emeritus), and Michael Rosbash, Brandeis University for the discovery of the molecular mechanisms governing circadian rhythms.
William Kaelin, Jr.; Steven McKnight; Peter J. Ratcliffe; Gregg L. Semenza for their work in oxygen sensing systems.
Evelyn M. Witkin and Stephen Elledge for their studies of the DNA damage response. [6]
Yoshinori Ohsumi for the discovery of how cells recycle their components in an orderly manner. This process, autophagy (self-eating), is critical for the maintenance and repair of cells and tissues.
Joachim Frank, Richard Henderson, and Marin van Heel for pioneering developments in electron microscopy.
Lynne E. Maquat for elucidating the mechanism of nonsense-mediated messenger RNA decay.
Svante Pääbo and David Reich for sequencing the genomes of ancient humans and extinct relatives.
No award due to the COVID-19 pandemic.
Clifford Brangwynne, Anthony Hyman, and Michael Rosen for a new principle of subcellular compartmentalization based on formation of phase-separated biomolecular condensates.
David Baker, Demis Hassabis, and John Jumper for pioneering studies in protein structure predictions.
Michael J. Welsh, Paul Negulescu, Fredrick Van Goor, and Sabine Hadida for research and development leading to medicines that effectively treat cystic fibrosis by correcting the folding, trafficking, and functioning of the mutated cystic fibrosis transmembrane regulator (CFTR). [7]
Judith Kimble, Allan Spradling, and Raymond Schofield for their discovery of the stem cell niche, a localized environment that controls stem-cell identity. [8]
George Emil Palade was a Romanian-American cell biologist. Described as "the most influential cell biologist ever", in 1974 he was awarded the Nobel Prize in Physiology and Medicine along with Albert Claude and Christian de Duve. The prize was granted for his innovations in electron microscopy and cell fractionation which together laid the foundations of modern molecular cell biology, the most notable discovery being the ribosomes of the endoplasmic reticulum – which he first described in 1955.
Howard Robert Horvitz ForMemRS NAS AAA&S APS NAM is an American biologist best known for his research on the nematode worm Caenorhabditis elegans, for which he was awarded the 2002 Nobel Prize in Physiology or Medicine, together with Sydney Brenner and John E. Sulston, whose "seminal discoveries concerning the genetic regulation of organ development and programmed cell death" were "important for medical research and have shed new light on the pathogenesis of many diseases".
Pamela Jane Bjorkman NAS, AAAS is an American biochemist and molecular biologist. She is the David Baltimore Professor of Biology and Biological Engineering at the California Institute of Technology (Caltech). Her research centers on the study of the three-dimensional structures of proteins related to Class I MHC, or Major Histocompatibility Complex, proteins of the immune system, and proteins involved in the immune responses to viruses. Bjorkman's goal is to improve current therapeutic applications. Bjorkman is most well known as a pioneer in the field of structural biology.
Peter Walter is a German-American molecular biologist and biochemist. He is currently the Director of the Bay Area Institute of Science at Altos Labs and an emeritus professor at the Department of Biochemistry and Biophysics of the University of California, San Francisco (UCSF). He was a Howard Hughes Medical Institute (HHMI) Investigator until 2022.
John Kuriyan is the dean of basic sciences and a professor of biochemistry at Vanderbilt University School of Medicine. He was formerly the Chancellor's Professor at the University of California, Berkeley in the departments of molecular and cell biology (MCB) and chemistry, a faculty scientist in Berkeley Lab's physical biosciences division, and a Howard Hughes Medical Institute investigator. He is a member of the National Academy of Sciences and he has also been on the Life Sciences jury for the Infosys Prize in 2009, 2019 and 2020.
The Max Planck Institute for Medical Research in Heidelberg, Germany, is a facility of the Max Planck Society for basic medical research. Since its foundation, six Nobel Prize laureates worked at the Institute: Otto Fritz Meyerhof (Physiology), Richard Kuhn (Chemistry), Walther Bothe (Physics), André Michel Lwoff, Rudolf Mößbauer (Physics), Bert Sakmann and Stefan W. Hell (Chemistry).
Arthur L. Horwich is an American biologist and Sterling Professor of Genetics and Pediatrics at the Yale School of Medicine. Horwich has also been a Howard Hughes Medical Institute investigator since 1990. His research into protein folding uncovered the action of chaperonins, protein complexes that assist the folding of other proteins; Horwich first published this work in 1989.
Franz-Ulrich Hartl is a German biochemist and the current Executive Director of the Max Planck Institute of Biochemistry. He is known for his pioneering work in chaperone-mediated protein folding.
The Dr. Paul Janssen Award for Biomedical Research is given annually by Johnson & Johnson to honor the work of an active scientist in academia, industry or a scientific institute in the field of biomedical research. It was established in 2004 and perpetuates the memory of Paul Janssen, the founder of Janssen Pharmaceutica, a Johnson & Johnson subsidiary.
Thomas Dean Pollard is a prominent educator, cell biologist and biophysicist whose research focuses on understanding cell motility through the study of actin filaments and myosin motors. He is Sterling Professor Emeritus of Molecular, Cellular & Developmental Biology and a professor emeritus of cell biology and molecular biophysics & biochemistry at Yale University. He was dean of Yale's Graduate School of Arts and Sciences from 2010 to 2014, and president of the Salk Institute for Biological Studies from 1996 to 2001.
Thomas Christian Südhof, ForMemRS, is a German-American biochemist known for his study of synaptic transmission. Currently, he is a professor in the school of medicine in the department of molecular and cellular physiology, and by courtesy in neurology, and in psychiatry and behavioral sciences at Stanford University.
Karl Alexander Deisseroth is an American scientist. He is the D.H. Chen Professor of Bioengineering and of psychiatry and behavioral sciences at Stanford University.
Ronald David Vale ForMemRS is an American biochemist and cell biologist. He is a professor at the Department of Cellular and Molecular Pharmacology, University of California, San Francisco. His research is focused on motor proteins, particularly kinesin and dynein. He was awarded the Canada Gairdner International Award for Biomedical Research in 2019, the Shaw Prize in Life Science and Medicine in 2017 together with Ian Gibbons, and the Albert Lasker Award for Basic Medical Research in 2012 alongside Michael Sheetz and James Spudich. He is a fellow of the American Academy of Arts and Sciences and a member of the National Academy of Sciences. He was the president of the American Society for Cell Biology in 2012. He has also been an investigator at the Howard Hughes Medical Institute since 1995. In 2019, Vale was named executive director of the Janelia Research Campus and a vice president of HHMI; his appointment began in early 2020.
Lynne Elizabeth Maquat is an American biochemist and molecular biologist whose research focuses on the cellular mechanisms of human disease. She is an elected member of the American Academy of Arts and Sciences, the National Academy of Sciences and the National Academy of Medicine. She currently holds the J. Lowell Orbison Endowed Chair and is a professor of biochemistry and biophysics, pediatrics and of oncology at the University of Rochester Medical Center. Professor Maquat is also Founding Director of the Center for RNA Biology and Founding Chair of Graduate Women in Science at the University of Rochester.
Kazutoshi Mori is a Japanese molecular biologist known for research on unfolded protein response. He is a professor of Biophysics at the Graduate School of Science, Kyoto University, and shared the 2014 Albert Lasker Basic Medical Research Award with Peter Walter for discoveries concerning the unfolded protein response — an intracellular quality control system that detects harmful misfolded proteins in the endoplasmic reticulum and signals the nucleus to carry out corrective measures.
Peter Hegemann is a Hertie Senior Research Chair for Neurosciences and a professor of Experimental Biophysics at the Department of Biology, Faculty of Life Sciences, Humboldt University of Berlin, Germany. He is known for his discovery of channelrhodopsin, a type of ion channels regulated by light, thereby serving as a light sensor. This created the field of optogenetics, a technique that controls the activities of specific neurons by applying light. He has received numerous accolades, including the Rumford Prize, the Shaw Prize in Life Science and Medicine, and the Albert Lasker Award for Basic Medical Research.
Georg Nagel is a biophysicist and professor at the Department for Neurophysiology at the University of Würzburg in Germany. His research is focused on microbial photoreceptors and the development of optogenetic tools.
Ernst Bamberg is a German biophysicist and director emeritus of the Department of Biophysical Chemistry at the Max Planck Institute of Biophysics.
Michael James Welsh is an American pulmonologist. He is the current Roy J. Carver Chair in Biomedical Research, the Professor of Internal Medicine in Pulmonary, Critical Care and Occupational Medicine at the Department of Internal Medicine, and the Director of Pappajohn Biomedical Institute, Roy J. and Lucille A. Carver College of Medicine, University of Iowa. He is also a professor at the Department of Neurosurgery, Department of Neurology, and Department of Molecular Physiology and Biophysics. He received the 2022 Shaw Prize in Life science and Medicine, together with Paul A. Negulescu, for their work that uncovered the etiology of cystic fibrosis and developed effective medications.
Joanna Wysocka is a biologist, a professor at Stanford University, and a Howard Hughes Medical Institute Investigator. She specializes in chemical and systems biology as well as developmental biology.